Salem Investment Counselors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.06M | Sell |
188,810
-12,722
| -6% | -$691K | 0.2% | 72 |
|
|
2026
Q1 | $12.6M | Buy |
201,532
+5,460
| +3% | +$437K | 0.37% | 47 |
|
|
2025
Q4 | $18.7M | Buy |
196,072
+236
| +0.1% | +$23.1K | 0.53% | 41 |
|
|
2025
Q3 | $19.1M | Buy |
195,836
+2,895
| +2% | +$300K | 0.55% | 36 |
|
|
2025
Q2 | $20.7M | Buy |
192,941
+95
| +0% | +$9.61K | 0.66% | 30 |
|
|
2025
Q1 | $19.5M | Sell |
192,846
-3,944
| -2% | -$397K | 0.68% | 31 |
|
|
2024
Q4 | $17.6M | Sell |
196,790
-15,857
| -7% | -$1.4M | 0.58% | 37 |
|
|
2024
Q3 | $17.8M | Buy |
212,647
+768
| +0.4% | +$60.5K | 0.54% | 39 |
|
|
2024
Q2 | $16.3M | Buy |
211,879
+661
| +0.3% | +$48.4K | 0.53% | 38 |
|
|
2024
Q1 | $14.5M | Buy |
211,218
+23,324
| +12% | +$1.5M | 0.48% | 41 |
|
|
2023
Q4 | $10.9M | Sell |
187,894
-10,360
| -5% | -$553K | 0.37% | 47 |
|
|
2023
Q3 | $10.5M | Buy |
198,254
+8,892
| +5% | +$466K | 0.4% | 45 |
|
|
2023
Q2 | $10.2M | Buy |
189,362
+25
| +0% | +$1.31K | 0.37% | 47 |
|
|
2023
Q1 | $9.47M | Sell |
189,337
-6,988
| -4% | -$329K | 0.38% | 48 |
|
|
2022
Q4 | $9.08M | Buy |
196,325
+900
| +0.5% | +$39K | 0.39% | 45 |
|
|
2022
Q3 | $7.57M | Buy |
195,425
+11,400
| +6% | +$457K | 0.34% | 50 |
|
|
2022
Q2 | $6.86M | Buy |
184,025
+30,419
| +20% | +$1.24M | 0.31% | 55 |
|
|
2022
Q1 | $6.8M | Buy |
153,606
+250
| +0.2% | +$10.8K | 0.27% | 61 |
|
|
2021
Q4 | $6.51M | Buy |
153,356
+5,115
| +3% | +$215K | 0.23% | 67 |
|
|
2021
Q3 | $6.43M | Buy |
148,241
+6,400
| +5% | +$283K | 0.35% | 59 |
|
|
2021
Q2 | $6.07M | Buy |
141,841
+1,400
| +1% | +$58.9K | 0.33% | 67 |
|
|
2021
Q1 | $5.43M | Sell |
140,441
-2,088
| -1% | -$79K | 0.33% | 67 |
|
|
2020
Q4 | $5.12M | Buy |
142,529
+4,513
| +3% | +$163K | 0.34% | 66 |
|
|
2020
Q3 | $5.27M | Hold |
138,016
| – | – | 0.4% | 59 |
|
|
2020
Q2 | $4.85M | Buy |
138,016
+170
| +0.1% | +$6.12K | 0.41% | 56 |
|
|
2020
Q1 | $4.5M | Buy |
137,846
+1,105
| +0.8% | +$43.2K | 0.47% | 54 |
|
|
2019
Q4 | $6.18M | Sell |
136,741
-445
| -0.3% | -$18.6K | 0.51% | 51 |
|
|
2019
Q3 | $5.58M | Sell |
137,186
-1,250
| -0.9% | -$53K | 0.51% | 50 |
|
|
2019
Q2 | $5.95M | Buy |
138,436
+545
| +0.4% | +$21K | 0.55% | 47 |
|
|
2019
Q1 | $5.31M | Buy |
137,891
+1,920
| +1% | +$73.3K | 0.54% | 47 |
|
|
2018
Q4 | $4.8M | Sell |
135,971
-1,920
| -1% | -$69.6K | 0.61% | 44 |
|
|
2018
Q3 | $5.31M | Sell |
137,891
-600
| -0.4% | -$21K | 0.54% | 47 |
|
|
2018
Q2 | $4.53M | Sell |
138,491
-450
| -0.3% | -$13.6K | 0.41% | 52 |
|
|
2018
Q1 | $3.73M | Buy |
138,941
+66
| +0% | +$1.79K | 0.42% | 60 |
|
|
2017
Q4 | $3.44M | Buy |
138,875
+13,700
| +11% | +$378K | 0.37% | 65 |
|
|
2017
Q3 | $3.68M | Buy |
125,175
+8,802
| +8% | +$243K | 0.43% | 59 |
|
|
2017
Q2 | $3.23M | Buy |
116,373
+13,973
| +14% | +$371K | 0.37% | 63 |
|
|
2017
Q1 | $2.55M | Sell |
102,400
-11,446
| -10% | -$278K | 0.27% | 89 |
|
|
2016
Q4 | $2.46M | Buy |
113,846
+20,271
| +22% | +$442K | 0.28% | 82 |
|
|
2016
Q3 | $22.3K | Buy |
93,575
+64,575
| +223% | +$1.54M | 0.29% | 81 |
|
|
2016
Q2 | $678K | Buy |
+29,000
| New | +$627K | 0.08% | 157 |
|
Other funds holding BSX
YIH
FFM
GI
CNB
QCM
P
CTI
NCM